|
FDA Amps Up Postmarket Focus With String of Public Meetings
Devicemakers will have an opportunity to air their concerns about the FDA’s postmarket surveillance system at a Sept. 10 public meeting in Greenbelt, Md.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives